Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E) (EGX:RMDA)

Egypt · Delayed Price · Currency is EGP

5.13

+0.04 (0.79%)

At close: May 14, 2026

Revenue by Segment

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Sales of Pharmaceutical Products	3.81B	2.59B	1.79B	1.35B	1.17B
Sales of Pharmaceutical Products Growth	47.33%	44.65%	32.32%	15.62%	28.55%
Services Toll Manufacturing	284.79M	181.87M	134.01M	132.44M	77.49M
Services Toll Manufacturing Growth	56.59%	35.71%	1.18%	70.91%	52.42%
Total	4.10B	2.77B	1.92B	1.48B	1.25B
Total Growth	47.94%	44.03%	29.54%	19.06%	29.81%

Revenue by Geography

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Egypt	3.85B	2.63B	1.74B	1.38B	1.16B
Egypt Growth	46.68%	50.76%	26.47%	18.89%	27.28%
Export	243.55M	142.20M	180.24M	106.51M	87.87M
Export Growth	71.27%	-21.11%	69.23%	21.21%	75.96%
Total	4.10B	2.77B	1.92B	1.48B	1.25B
Total Growth	47.94%	44.03%	29.54%	19.06%	29.81%

Source: S&P Global Market Intelligence.